On the Record · Iqvia
Iqvia competitors, on the record
The companies Iqvia names as competitors in its annual reports, 2023 to 2025, and the companies that name Iqvia, each with the sentence and the filing.
Who Iqvia names
| Company | Named in |
|---|---|
| Accenture | 2025 |
| Amplity Health | 2025 |
| CMIC HOLDINGS Co., Ltd. | 2025 |
| EPS Corporation | 2025 |
| Eversana | 2025 |
| Inizio | 2025 |
| Syneos Health | 2025 |
| Uniphar | 2025 |
In its own words
Accenture
Word for word“Our offerings compete with various firms, including Accenture, Aetion (a Datavant company), Panalgo (a Norstella company), Cognizant Technology Solutions, Deloitte, Pharmaceutical Product Development, Inc. (part of Thermo Fisher Scientific Inc.), Relx, IBM, Infosys, Oracle Health, McKinsey, NielsenIQ, Optum Insight (part of UnitedHealth Group), Parexel International Corporation, Press Ganey, RTI Health Solutions, ICON plc, Definitive Healthcare, Cegedim, Tempus, Merative, CompuGroup Medical, Medidata (Part of Dassault Systèmes), Clarivate, Veeva, and ZS Associates.” 10-K for 2025
Amplity Health, Eversana, Inizio
Word for word“Contract Sales & Medical Solutions’ primary competitors in the United States are Syneos Health, Amplity Health, Eversana and Inizio.” 10-K for 2025
CMIC HOLDINGS Co., Ltd., EPS Corporation, Uniphar
Word for word“Outside of the United States, Contract Sales & Medical Solutions typically competes against single country or more regionally focused service providers, such as Inizio, Syneos Health, EPS Corporation, Uniphar, and CMIC HOLDINGS Co., Ltd.” 10-K for 2025
Syneos Health
Word for word“Some of our larger competitors include ICON plc, Parexel International Corporation, Pharmaceutical Product Development, Inc. (part of Thermo Fisher Scientific Inc.), and Syneos Health, among others.” 10-K for 2025
Who names Iqvia
Companies whose own annual reports name Iqvia as a competitor.
Word for word“When competing for large development programs, ICON competes primarily with IQVIA, PAREXEL, the PPD clinical research services brand of Thermo Fisher Scientific Inc., Fortrea and Syneos Health.” 20-F for 2025
Word for word“Our major CRO competitors include IQVIA Holdings Inc., ICON plc, PPD, Inc. (now part of Thermo Fisher Scientific Inc.), Fortrea, Inc., and numerous specialty and regional CROs.” 10-K for 2025
Word for word“Our principal traditional CRO competitors are ICON plc, IQVIA Holdings Inc., Laboratory Corporation of America Holdings, PAREXEL International Corporation, PPD, Inc., and Syneos Health, Inc.” 10-K for 2020
Word for word“Our main competitors in this area are Flatiron Health, Inc., IQVIA Holdings Inc., ConcertAI, and others.” 10-K for 2025
Word for word“Our Veeva Data Cloud products, as well as Veeva Crossix, compete with IQVIA Holdings, Inc., Ipsos Group S.A., Definitive Health Corp., and smaller data and data analytics providers.” 10-K for 2026
Read from Iqvia’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-17. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.